Abstract
Tumor necrosis factor-alpha (TNF-α) is pleiotropic mediator of a diverse array of physiological and neurological functions, including both normal regulatory functions and immune responses to infectious agents. Its role in the nervous system is prominent but paradoxical. Studies on uninflamed or “normal” brain have generally attributed TNF-α a neuromodulatory effect. In contrast, in inflamed or diseased brain, the abundance of evidence suggests that TNF-α has an overall neurotoxic effect, which may be particularly pronounced for virally mediated neurological disease. Still others have found TNF-α to be protective under some conditions of neurological insult. It is still uncertain exactly how TNF-α is able to induce these opposing effects through receptor activation of only a limited set of cell signaling pathways. In this paper, we provide support from the literature to advance our hypothesis that one mechanism by which TNF-α can exert its paradoxical effects in the brain is via crosstalk with signaling pathways of growth factors or other cytokines.
Article PDF
Similar content being viewed by others
References
Ameloot P, Fiers W, De Bleser P, Ware CF, Vandenabeele P, Brouckaert P (2001). Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants. J Biol Chem 276: 37426–37430.
Ariga T, Jarvis WD, Yu RK (1998). Role of sphingolipid-mediated cell death in neurodegenerative diseases. J Lipid Res 39: 1–16.
Askovic S, Favara C, McAtee FJ, Portis JL (2001). Increased expression of MIP-1 alpha and MIP-1 beta mRNAs in the brain correlates spatially and temporally with the spongiform neurodegeneration induced by a murine on-cornavirus. J Virol 75: 2665–2674.
Bahr BA, Bendiske J, Brown QB, Munirathinam S, Caba E, Rudin M, Urwyler S, Sauter A, Rogers G (2002). Survival signaling and selective neuroprotection through glutamatergic transmission. Exp Neurol 174: 37–47.
Baker SJ, Reddy EP (1998). Modulation of life and death by the TNF receptor superfamily. Oncogene 17: 3261–3270.
Barker V, Middleton G, Davey F, Davies AM (2001). TNF alpha contributes to the death of NGF-dependent neurons during development. Nat Neurosci 4: 1194–1198.
Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997). Tumor necrosis factor-α: a mediator of focal ischemic brain injury. Stroke 28: 1233–1244.
Bencsik A, Malcus C, Akaoka H, Giraudon P, Belin MF, Bernard A (1996). Selective induction of cytokines in mouse brain infected with canine distemper virus: structural, cellular and temporal expression. J Neuroimmunol 65: 1–9.
Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A (2001). CXCR4-activated astrocyte glutamate release via TNF-alpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4: 702–710.
Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, Gennarelli M (2001). Association between G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 6: 79–82.
Boka G, Anglade P, Wallach D, Javoy-Agid F (1994). Immunocytochemical analysis of TNF and its receptors in Parkinson’s disease. Neurosci Lett 172: 151–154.
Bredow S, Guha-Thakurta N, Taishi P, Obal F Jr, Krueger JM (1997). Diurnal variations of tumor necrosis factor alpha mRNA and alpha-tubulin mRNA in rat brain. Neuroimmunomodulation 4: 84–90.
Brink R, Lodish HF (1998). Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-κB activation. J Biol Chem 273: 4129–4134.
Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP (1996). Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2: 788–794.
Brugg B, Michel PP, Agid Y, Ruberg M (1996). Ceramide induces apoptosis in cultured mesencephalic neurons. J Neurochem 66: 733–739.
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666–3670.
Casaccia-Bonnefil P, Gu C, Chao MV (1999). Neurotrophins in cell survival/death decisions. In: The functional roles of glial cells in health and disease. Matsas R, Tsacopoulos M (eds). Kluwer/Plenum: New York, pp 275–282.
Castagne V, Lefevre K, Clarke PG (2001). Dual role of the NF-kappaB transcription factor in the death of immature neurons. Neuroscience 108: 517–526.
Cermelli C, Jacobson S (2000). Viruses and multiple sclerosis. Viral Immunol 13: 255–267.
Cheeran MC, Hu S, Yager SL, Gekker G, Peterson PK, Lokensgard JR (2001). Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J NeuroVirol 7: 135–147.
Craig LE, Sheffer D, Meyer AL, Hauer D, Lechner F, Peterhans E, Adams RJ, Clements JE, Narayan O, Zink MC (1997). Pathogenesis of ovine lentiviral encephalitis: derivation of a neurovirulent strain by in vivo passage. J NeuroVirol 3: 417–427.
Dantzer R (2001). Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15: 7–24.
Dawson TM (2002). Preconditioning-mediated neuroprotection through erythropoietin? Lancet 359: 96–97.
Digicaylioglu M, Lipton SA (2001). Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641–647.
Dopp JM, Mackenzie GA, Otero GC, Merrill JE (1997). Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 75: 104–112.
Eder J (1997). Tumour necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol Sci 18: 319–322.
Epstein L, Gelbard HA (1999). HIV-1-induced neuronal injury in the developing brain. J Leukoc Biol 65: 453–457.
Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R, Johnson EM Jr (1994). Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127 (6 Pt 1): 1717–1727.
Eves EM, Skoczylas C, Yoshida K, Alnemri ES, Rosner MR (2001). FGF induces a switch in death receptor path-wasys in neuronal cells. J Neurosci 21: 4996–5006.
Feng P, Chan SH, Ooi EE, Soo MY, Loh KS, Wang D, Ren EC, Hu H (1999). Elevated blood levels of soluble tumor necrosis factor receptors in nasopharyngeal carcinoma: correlation with humoral immune response to lytic replication of Epstein-Barr virus. Int J Oncol 15: 167–172.
Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U (2002). Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 22: 216.
Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP (1998). Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18: 1283–1287.
Goswami R, Dawson G (2000). Does ceramide play a role in neural cell apoptosis? J Neurosci Res 60: 141–149.
Grazia De Simoni M, Imeri L (1998). Cytokine-neurotransmitter interactions in the brain. Biol Signals Receptors 7: 33–44.
Griffin DE (1997). Cytokines in the brain during viral infection: clues to HIV-associated dementia. J Clin Invest 100: 2948–2951.
Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL (1995). A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927–939.
Haviv R, Stein R (1999). Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells. J Neurosci Res 55: 269–2 77.
Hemmer B, Cepok S, Nessler S, Sommer N (2002). Pathogenesis of multiple sclerosis: an update on immunology. Curr Opin Neurol 15: 227–231.
Hoffman PM, Dhib-Jalbut S, Mikovits JA, Robbins DS, Wolf AL, Bergey GK, Lohrey NC, Weislow OS, Ruscetti FW (1992). Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc Natl Acad Sci USA 89: 11784–11788.
Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC (2000). Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7: 153–159.
Iida R, Saito K, Yamada K, Basile AS, Sekikawa K, Takemura M, Fujii H, Wada H, Seishima M, Nabeshima T (2000). Suppression of neurocognitive damage in LP-BM5-infected mice with a targeted deletion of the TNF-alpha gene. FASEB J 14: 1023–1031.
Itzhaki RF, Dobson CB (2002). Alzheimer’s disease and herpes. Can Med Assoc J 167: 13.
Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH (1997). Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int J Dev Neurosci 15: 711–716.
Jones SJ, Ledgerwood EC, Prins JB, Galbraith J, Johnson DR, Pober JS, Bradley JR (1999). TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J Immunol 162: 1042–1048.
Kassiotis G, Kollias G (2001). Uncouplingthe proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 193: 427–434.
Kim WG, Mahoney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000). Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20: 6309–6316.
Knoblach SM, Fan L, Faden AI (1999). Early neuronal expression of tumor necrosis factor-α after experimental brain injury contributes to neurological impairment. J Neuroimmunol 95: 115–125.
Koh C, Inoue A, Yamazaki M, Kim BS (2000). High-dose mouse immunoglobulin G administration suppresses Theiler’s murine encephalomyelitis virus-induced demyelinating disease. J Neuroimmunol 108: 22–28.
Kraus J, Kuehne BS, Tofighi J, Frielinghaus P, Stolz E, Blaes F, Laske C, Engelhardt B, Traupe H, Kaps M, Oschmann P (2002). Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis. Acta Neurol Scand 105: 300–308.
Kronfol Z, Remick DG (2000). Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157: 683–694.
Krueger JM, Fang J, Taishi P, Chen Z, Kushikata T, Gardi J (1998). Sleep: a physiologic role for IL-1 beta and TNF-alpha. Ann NY Acad Sci 856: 148–159.
Kustova Y, Espey MG, Sung EG, Morse D, Sei Y, Basile AS (1998). Evidence of neuronal degeneration in C57B1/6 mice infected with the LP-BM5 leukemia retrovirus mixture. Mol Chem Neuropathol 35: 39–59.
Ledgerwood EC, Pober JS, Bradley JR (1999). Recent advances in the molecular basis of signal transduction. Lab Invest 79: 1041–1450.
Licinio J, Wong ML (1997). Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 100: 2941–2947.
Lin MT, Hinton DR, Parra B, Stohlman SA, van der Veen RC (1998). The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology 245: 270–280.
Loddick SA, Rothwell NJ (1999). Mechanisms of tumor necrosis factor-α action on neurodegeneration: interaction with insulin-like growth factor-1. Proc Natl Acad Sci USA 96: 9449–9451.
MacDonald NJ, Perez-Polo JR, Bennett AD, Taglialatela G (1999). NGF-resistant PC12 cell death induced by arachidonic acid is accompanied by a decrease of active PKC zeta and nuclear factor kappa B. J Neurosci Res 57: 219–226.
Maggirwar SB, Ramirez S, Tong N, Gelbard HA, Dewhurst S (2000). Functional interplay between nuclear factor-kappaB and c-Jun integrated by coactivator p300 determines the survival of nerve growth factor-dependent PC12 cells. J Neurochem 74: 527–539.
Marchetti C, Ulisse S, Bruscoli S, Russo FP, Migliorati G, Schiaffella F, Cifone MG, Riccardi C, Fringuelli R (2002). Induction of apoptosis by 1,4-benzothiazine analogs in mouse thymocytes. J Pharmacol Exp Ther 300: 1053–1062.
Mattson MP, Barger SW, Furukawa K, Bruce AJ, Wyss-Cory T, Mark RJ, Mucke L (1997). Cellular signaling roles of TGFb, TNFa, and bAPP in brain injury responses and Alzheimer’s disease. Brain Res Rev 23: 47–61.
Mayne M, Ni W, Yan HJ, Xue M, Johnston JB, Del Bigio MR, Peeling J, Power C (2001). Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage. Stroke 32: 240–248.
Molina-Holgado F, Hernanz A, De la Fuente M, Guaza C (1999). N-Acetyl-cysteine inhibition of encephalomyelitis Theiler’s virus-induced nitric oxide and tumour necrosis factor-alpha production by murine astrocyte cultures. Biofactors 10: 187–193.
Munoz-Fernandez MA, Fresno M (1998). The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56: 307–340.
Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ (1997). Tumor necrosis factor-α: a neuromodulator in the CNS. Neurosci Biobehav Rev 21: 603–613.
Pelagi M, Curnis F, Colombo B, Rovere P, Sacchi A, Manfredi AA, Corti A (2000). Caspase inhibition reveals functional cooperation between p55- and p75-TNF receptors in cell necrosis. Eur Cytokine Networks 11: 580–588.
Perini G, Della-Bianca V, Politi V, Della Valle G, Dal-Pra I, Rossi F, Armato U (2002). Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 195: 907–918.
Perry RT, Collins JS, Wiener H, Acton R, Go RC (2001). The role of TNF and its receptors in Alzheimer’s disease. Neurobiol Aging 22: 873–883.
Peterson KE, Robertson SJ, Portis JL, Chesebro B (2001). Differences in cytokine and chemokine responses during neurological disease induced by polytropic murine retroviruses Map to separate regions of the viral envelope gene. J Virol 75: 2848–2856.
Plata-Salaman CR, Oomura Y, Kai Y (1988). Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res 448: 106–114.
Poli A, Pistello M, Carli MA, Abramo F, Mancuso G, Nicoletti E, Bendinelli M (1999). Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus. J NeuroVirol 5: 465–473.
Rath PC, Aggarwal BB (1999). TNF-induced signaling in apoptosis. J Clin Immunol 19: 350–364.
Rauca C, Zerbe R, Jantze H, Krug M (2000). The importance of free hydroxyl radicals to hypoxia preconditioning. Brain Res 868: 147–149.
Rothwell N, Allan S, Toulmond S (1997). The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 100: 2648–2652.
Ryan LA, Zheng J, Brester M, Bohac D, Hahn F, Anderson J, Ratanasuwan W, Gendelman HE, Swindells S (2001). Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J Infect Dis 184: 699–706.
Scherbel U, Raghupathi R, Nakamura M, Saatman KE, McIntosh TK (1997). Evaluation of neurobehavioral deficits in brain injured tumor necrosis factor-deficient (TNF− /−) mice after experimental brain injury. J Neurotrauma 14: 781.
Sei Y, Nishida K, Kustova Y, Markey SP, Morse HC 3rd, Basile AS (1997). Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS. Eur J Pharmacol 325: 81–84.
Shinmura Y, Kosugi I, Kaneta M, Tsutsui Y (1999). Migration of virus-infected neuronal cells in cerebral slice cultures of developing mouse brains after in vitro infection with murine cytomegalovirus. Acta Neuropathol (Berl) 98: 590–596.
Shinpo K, Kikuchi S, Moriwaka F, Tashiro K (1999). Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Res 819: 170–173.
Shohami E, Ginis I, Hallenback JM (1999). Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev 10: 119–130.
Sipe KJ, Dantzer R, Kelley KW, Weyhenmeyer JA (1998). Expression of the 75kDA TNF receptor and its role in contact mediated neuronal cell death. Mol Brain Res 62: 111–121.
Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, Olah Z, Olivera A, Pirianov G, Thomas DM, Tu Z, Van Brocklyn JR, Wang F (1998). Sphingosine-1-phosphate in cell growth and cell death. Ann NY Acad Sci 845: 11–18.
Sternberg EM (1997). Neural-immune interactions in health and disease. J Clin Invest 100: 2641–2647.
Stoll G, Jander S, Schroeter M (2000). Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J Neural Transm Suppl 59: 81–89.
Sun N, Grzybicki D, Castro RF, Murphy S, Perlman S (1995). Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213: 482–493.
Takano R, Hisahara S, Namikawa K, Kiyama H, Okano H, Miura M (2000). Nerve growth factor protects oligo-dendrocytes from tumor necrosis factor-α-induced injury through Akt-mediated signaling mechanisms. J Biol Chem 275: 16360–16365.
Tong CY, Bakran A, Williams H, Cuevas LE, Peiris JS, Hart CA (2001). Association of tumour necrosis factor alpha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation. J Med Virol 64: 29–34.
Trgovcich J, Aronson JF, Eldridge JC, Johnston RE (1999). TNF-alpha, interferon, and stress response induction as a function of age-related susceptibility to fatal Sindbis virus infection of mice. Virology 263: 339–348.
Ubalee R, Suzuki F, Kikuchi M, Tasanor O, Wattanagoon Y, Ruangweerayut R, Na-Bangchang K, Karbwang J, Kimura A, Itoh K, Kanda T, Hirayama K (2001). Strong association of a tumor necrosis factor-alpha promoter allele with cerebral malaria in Myanmar. Tissue Antigen 58: 407–410.
Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW (1999). A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 96: 9879–9884.
Verreault R, Laurin D, Lindsay J, De Serres G (2001). Past exposure to vaccines and subsequent risk of Alzheimer’s disease. Can Med Assoc J 165: 1495–1498.
Vitkovic L, Bockaert J, Jacque C (2000). “Inflammatory” cytokines: neuromodulators in normal brain? J Neurochem 74: 457–471.
Wang E, Marcotte R, Petroulakis E (1999). Signaling pathway for apoptosis: a racetrack for life or death. J Cell Biochem Suppl 1/2: 95–102.
Wesselingh SL, Power C, Glass JD, Tyor WR, MacArthur JC, Farber JM, Griffin JW, Griffin DE (1993). Intracerebral cytokine messenger RNA expression in acquired immune deficiency syndrome dementia. Ann Neurol 33: 576–582.
Wilde GJ, Pringle AK, Sundstrom LE, Mann DA, Iannotti F (2000). Attenuation and augmentation of ischaemia-related neuronal death by tumour necrosis factor-alpha in vitro. Eur J Neurosci 12: 3863–3870.
Yang L, Lindholm K, Konishi Y, Li R, Shen Y (2002). Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J Neurosci 22: 3025–3032.
Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF (2000). Endogenous retroviruses and schizophrenia. Brain Res Rev 31: 193–199.
Author information
Authors and Affiliations
Corresponding authors
Additional information
These studies were funded in part by NIH grants T32 AI49815 (SWP and SD); R01 MH56838 (SD and HAG); and P01 MH64570 (SD and HAG).
MJB is a trainee in the Medical Scientist Training Program, NIH T32 GM07356.
Rights and permissions
About this article
Cite this article
Perry, S.W., Dewhurst, S., Bellizzi, M.J. et al. Tumor necrosis factor-alpha in normal and diseased brain: Conflicting effects via intraneuronal receptor crosstalk?. Journal of NeuroVirology 8, 611–624 (2002). https://doi.org/10.1080/13550280290101021
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280290101021